Skip to main content
/
Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
26.78
-0.14 (-0.52%)
At close: May 1, 2025, 4:00 PM
27.49
+0.71 (2.65%)
Pre-market: May 2, 2025, 4:10 AM EDT

Galapagos NV Revenue

Galapagos NV had revenue of 74.98M EUR in the quarter ending March 31, 2025, with 20.09% growth. This brings the company's revenue in the last twelve months to 288.19M, up 18.31% year-over-year. In the year 2024, Galapagos NV had annual revenue of 275.65M with 14.99% growth.

Revenue (ttm)
288.19M EUR
Revenue Growth
+18.31%
P/S Ratio
5.73
Revenue / Employee
409,366 EUR
Employees
704
Market Cap
1.79B USD

Revenue Chart

Created with Highcharts 11.4.8Galapagos NV Revenue - Annual478.1M​478.1M234.4M​234.4M241.2M​241.2M239.7M​239.7M275.6M​275.6M20202021202220232024-100M200M300M400M500M
* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024275.65M35.93M14.99%
Dec 31, 2023239.72M-1.53M-0.63%
Dec 31, 2022241.25M6.87M2.93%
Dec 31, 2021234.38M-243.67M-50.97%
Dec 31, 2020478.05M-356.85M-42.74%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.90B
Revenue Rankings

GLPG News

More News